We'd appreciate your feedback. Send feedback Subscribe to our newsletters and alerts


Asian Journal of Current Research in Clinical Cancer

2024 Volume 4 Issue 2

A Three-Decade Overview of Female-Specific Cancers in Malaysia: A Thorough Examination


, , , , , ,
  1. Institute of Pharmaceutical Sciences, University of Veterinary and Animal Sciences, Lahore, Pakistan.
  2. Ruth Pfau College of Nutrition Sciences, Lahore University of Biological and Applied Sciences, Lahore, Pakistan.
  3. Department of Clinical Pharmacy & Pharmacotherapeutics, Dubai Pharmacy College for Girls, Al Mizhar, Dubai, United Arab Emirates.
  4. Department of Urology Al Tadawi Specialty Hospital, Garhoud Dubai, United Arab Emirates.
  5. Department of Family Medicine, Canadian Specialist Hospital, Abu Hail, Dubai United Arab Emirates.
Abstract

The purpose of this research is to analyze the epidemiological trends of female-specific cancers in Malaysia. The review included studies from various sources, including the Asian Pacific Journal for Cancer Prevention, as well as databases like PubMed, Medline, Wiley Online Library, and ProQuest Central. The selected studies were published in various languages and covered all types of trials on patients of any age, between 1980 and 2016. The findings highlighted that Chinese women had the highest incidence of breast cancer, with a relative difference (RD) of 0.42 (CI = 0.41-0.43). Malay women showed a 22% higher likelihood of developing breast cancer compared to Indian women (RD = 0.22, CI = 0.21, 0.22), but 20% lower compared to Chinese women (RD = -0.20, CI = -0.21, -0.19). Cervical cancer held the second spot, with an average age-standardized rate (ASR) of 17.3. Indian women had the least risk of cervical cancer in comparison to Malays (RD = 0.22, CI = 0.18, 0.26) and Chinese women (RD = 0.46, CI = 0.41, 0.51). Ovarian cancer ranked fourth in frequency, with an ASR of 7.3. Indian women exhibited a lower risk of ovarian cancer than Chinese (RD = 0.29, CI = 0.27, 0.31) and Malay women (RD = 0.36, CI = 0.34, 0.38). By 2008, endometrial cancer ranked sixth among female cancers with an ASR of 6.5. Malay women had a slightly reduced risk of endometrial carcinoma compared to Chinese women (RD = -0.06, CI = -0.09, -0.03) but had a higher risk than Indian women (RD = 0.25, CI = 0.23, 0.28). The age group of 50-59 years saw the highest incidence for both breast and cervical cancers. Endometrial cancer was most common in women aged 60-69 years, while the risk of ovarian cancer began to rise significantly after the age of 40 years.


How to cite this article
Vancouver
Khan TM, Tahir H, Adil Q, Baig MR, Jaber AAS, Khaliel AM, et al. A Three-Decade Overview of Female-Specific Cancers in Malaysia: A Thorough Examination. Asian J Curr Res Clin Cancer. 2024;4(2):5-18. https://doi.org/10.51847/LIdazW7afN
APA
Khan, T. M., Tahir, H., Adil, Q., Baig, M. R., Jaber, A. A. S., Khaliel, A. M., & Mohammed, Z. M. (2024). A Three-Decade Overview of Female-Specific Cancers in Malaysia: A Thorough Examination. Asian Journal of Current Research in Clinical Cancer, 4(2), 5-18. https://doi.org/10.51847/LIdazW7afN
Articles
Tolerability of Chemoradiotherapy in Geriatric Patients with Pancreatic Cancer
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | İrem Sarıcanbaz
Environmental Impact of the Y-Isomer of HCH: Unveiling Its Role in Cancer Formation
Asian Journal of Current Research in Clinical Cancer
Vol 2 Issue 2, 2022 | Mata Uvaysovna Razhaeva
An Overview of Targeted Therapy Applications in Cancer Treatment
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | Yeuan Ting Lee
Exploring Advanced Diagnostic Techniques for Salivary Gland Disorders: A Narrative Overview
Asian Journal of Current Research in Clinical Cancer
Vol 4 Issue 1, 2024 | Chuan Xiang Li
Alternative Perspective on Cancer Based on the Interaction between Plasma Radiation and DNA
Asian Journal of Current Research in Clinical Cancer
Vol 2 Issue 1, 2022 | Mahmoud Mohamed Ahmed
Theoretical Model of Thiophene and Its Derivatives Interaction with BRCA-1
Asian Journal of Current Research in Clinical Cancer
Vol 4 Issue 2, 2024 | Lauro FigueroaValverde
Tolerability of Chemoradiotherapy in Geriatric Patients with Pancreatic Cancer
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | İrem Sarıcanbaz
An Overview of Targeted Therapy Applications in Cancer Treatment
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | Yeuan Ting Lee
Evaluating the Effects of Plasma Irradiation and Stevia on Gene Expression and Immune Responses in HepG2 Cells
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | Fatma Hussein Abdelwahab
Long-Term Survival Outcomes of Colorectal Cancer Survivors: An In-Depth Exploration
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | Zhaobei Cai
Superficial Basal Cell Carcinoma of the Nipple Mimicking Paget’s Disease of the Breast
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | Ahmed Samaouel Chehad
Exploring the Radiosensitizing Effects of Tolmetin in Radiotherapy for Human Clonal Cancer Cells
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | Deep Kwatra

About GalaxyPub

Find out more

Our esteemed publisher is committed to advancing medical knowledge through rigorous research dissemination. We exclusively accept submissions related to the field of medicine.

Our journals provide a platform for clinicians, researchers, and scholars to share groundbreaking discoveries, clinical insights, and evidence-based practices. By maintaining this specialized focus, we ensure that their publications contribute significantly to the advancement of healthcare worldwide.